NASDAQ:LHCGLHC Group Stock Price, Forecast & News

LHC Group's stock was trading at $127.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LHCG stock has increased by 24.5% and is now trading at $158.17. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for LHC Group.

LHC Group is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for LHC Group.

LHC Group, Inc. (NASDAQ:LHCG) announced its earnings results on Thursday, May, 7th. The health services provider reported $0.75 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.69 by $0.06. The health services provider earned $512.90 million during the quarter, compared to analysts' expectations of $504.41 million. LHC Group had a return on equity of 8.89% and a net margin of 4.73%. The business's revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.98 EPS. View LHC Group's earnings history.

10 brokers have issued 1 year price objectives for LHC Group's shares. Their forecasts range from $120.00 to $200.00. On average, they expect LHC Group's share price to reach $160.11 in the next twelve months. This suggests a possible upside of 1.2% from the stock's current price. View analysts' price targets for LHC Group.

News stories about LHCG stock have been trending extremely negative this week, InfoTrie reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. LHC Group earned a daily sentiment score of -4.4 on InfoTrie's scale. They also assigned news articles about the health services provider a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the stock's share price in the near term. View the latest news aboutLHC Group.

LHC Group saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,240,000 shares, a decline of 12.7% from the April 30th total of 1,420,000 shares. Based on an average daily trading volume, of 461,500 shares, the short-interest ratio is currently 2.7 days. Approximately 4.1% of the shares of the company are short sold. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), Home Depot (HD), Alibaba Group (BABA), Cisco Systems (CSCO), CVS Health (CVS), Chevron (CVX), Honeywell International (HON), Intel (INTC), Visa (V) and Walt Disney (DIS).

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.98%), Invesco Ltd. (5.61%), Wellington Management Group LLP (3.49%), State Street Corp (2.95%), Victory Capital Management Inc. (2.09%) and Victory Capital Management Inc. (2.09%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View institutional ownership trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Alliancebernstein L.P., GW&K Investment Management LLC, Magnetar Financial LLC, Morgan Stanley, Morgan Stanley, Summit Creek Advisors LLC, and Rothschild & Co. Asset Management US Inc.. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, and John L Indest. View insider buying and selling activity for LHC Group.

LHCG stock was purchased by a variety of institutional investors in the last quarter, including Invesco Ltd., Eagle Asset Management Inc., Eaton Vance Management, BlackRock Inc., TimesSquare Capital Management LLC, Thrivent Financial for Lutherans, Wellington Management Group LLP, and Ziegler Capital Management LLC. View insider buying and selling activity for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $158.17.

LHC Group has a market capitalization of $5.00 billion and generates $2.08 billion in revenue each year. The health services provider earns $95.73 million in net income (profit) each year or $4.47 on an earnings per share basis. LHC Group employs 30,399 workers across the globe.

The official website for LHC Group is www.lhcgroup.com.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]